Prosecution Insights
Last updated: October 25, 2026

Ice Miller LLP

Technology area: Biotechnology & Pharmaceuticals

123 pending office actions • 93 clients • 118 examiners • 88 art units • 0 of 123 (0%) have an AI response strategy ready

Analysis

ICE MILLER LLP has 118 pending office actions in Biotechnology & Pharmaceuticals and 4333 career applications. The profile shows a substantial prosecution base and an active unresolved workload in a technically demanding field.

The resolved allowance rate is 84.01%, and the average is 3.24 office actions per allowance. These figures indicate that many resolved matters reach allowance, while successful prosecution commonly involves more than one examination response.

Practitioners should combine portfolio-level consistency with application-specific analysis of biological support, therapeutic scope, and the evidentiary record needed to answer technical rejections.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=4333 apps, methodology: how we score firms)

84.0%
Allowance Rate
n=4333
+0.59σ
Allowance Rate (norm)
n=4333
3.2
OAs to Allowance
n=2270
-0.19σ
OAs to Allow (norm)
n=2270
954 days
Time to Allowance
n=2270
+12.4pp
Interview Lift
n=4333
25.3%
RCE Rate
n=4333
1.6%
Appeal Rate
n=4333

Rejection Performance (% of received rejections ultimately overcome)

66.9%
§101 Overcome
n=341
74.8%
§102 Overcome
n=993
74.0%
§103 Overcome
n=1519
75.8%
§112 Overcome
n=1351

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
23%
Top-3 CPC Share
n=4333
18
Practitioners
n=4333
240.7
Apps / Practitioner
n=4333

Portfolio Summary

123
Total Pending OAs
79
Non-Final OAs
36
Final Rejections
8
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 31 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

22
Overdue
0
Due this week
6
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 31 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (22)Due ≤ 30 days (6)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

76
Hard (62%)
38
Medium (31%)
9
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only4 (3%)
§101 + other25 (20%)
§103 only26 (21%)
§102 only3 (2%)
§112 only8 (7%)
Double-patenting only1 (1%)
Double-patenting + other9 (7%)
Multi-statute (no §101)47 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

62
Life Sciences
50% of docket
13
Information Tech
11% of docket
2
Communications
2% of docket
6
Semiconductors
5% of docket
38
Mechanical / Eng
31% of docket
2
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,230 h
Manual time on pending OAs
246 h
Time saved (low, 20%)
430 h
Time saved (mid, 35%)
10.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZEROUAL, OMAR 3 33.6% +39.6%
HOFFA, ANGELA MARIE 3 67.7% +28.1%
THOMPSON, CURTIS A 2 61.2% +51.6%
DELICH, STEPHANIE ZAGARELLA 1 38.7% +35.6%
STEWART, CRYSTOL 1 33.6% +28.8%
DO, NHAT CHIEU Q 1 64.0% +48.7%
GAVIN, KRISTIN ELIZABETH 1 14.9% +17.3%
GARCIA-GUERRA, DARLENE 1 23.2% +34.4%
MILLER, SERENITY A 1 68.5% +36.1%
JACKSON-TONGUE, LAKIA J 1 69.0% +20.8%

Hard Cases (76)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18635402 INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) AULAKH, CHARANJIT 475d overdue
18793346 SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS ZEROUAL, OMAR 147d overdue
17731451 COMPUTER-IMPLEMENTED CONVERSION OF TECHNICAL DRAWING DATA REPRESENTING A MAP AND OBJECT DETECTION BASED THEREUPON MOLL, NITHYA JANAKIRAMAN 88d overdue
18729134 STATISTICAL DATA ACQUISITION DEVICE, DEGREE OF CONTRIBUTION CALCULATION DEVICE, TREATMENT ACTION SEARCH DEVICE, TREATMENT OBJECT SEARCH DEVICE, STATISTICAL DATA ACQUISITION PROGRAM, DEGREE OF CONTRIBUTION CALCULATION PROGRAM, TREATMENT ACTION SEARCH PROGRAM, AND TREATMENT OBJECT SEARCH PROGRAM LEE, ANDREW ELDRIDGE 72d overdue
18127221 DIFFUSER SECURED TO CONTAINER DRAWING OIL FRAGRANCE INTO DIFFUSER ELEMENT VIA CAPILLARY ACTION PHAM, TUONGMINH NGUYEN 32d overdue
18261205 A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM LOUIS, LATOYA M 16d overdue
17756379 RETAINING DEVICE FOR A URINARY CATHETER AND ASSEMBLY COMPRISING A RETAINING DEVICE WITH A CATHETER VARGAS, ANNA ELIZABETH 15d overdue
18494851 Method of using a handheldable pulling and compressing device for repair of motor vehicle components KAKARLA, BHASKAR 9d overdue

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18793346 SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS ZEROUAL, OMAR 147d overdue
17259992 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION THOMPSON, CURTIS A 5d overdue
17260000 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION THOMPSON, CURTIS A 5d overdue
18949952 SYSTEMS AND METHODS FOR INTEGRATING REAL-TIME BUSINESS INSIGHTS ZEROUAL, OMAR 34d
19560331 SYSTEMS AND METHODS FOR REVENUE INTELLIGENT DIGITAL ASSISTANT USING REAL-TIME DATA MESH DELICH, STEPHANIE ZAGARELLA —
19559235 SYSTEMS AND METHODS FOR DYNAMIC PRICING OPTIMIZATION BASED ON CUSTOMER WILLINGNESS TO PAY STEWART, CRYSTOL —
19558117 HIGH STIFFNESS BOOSTER WITH COMPLIANT SUPPORT TABS AT NODE OR ANTINODE POSITIONS AND ULTRASONIC WELDING APPARATUS INCLUDING SAME DO, NHAT CHIEU Q —
19400243 SYSTEMS AND METHODS FOR MULTI-TIERED SUBSCRIPTION MANAGEMENT GAVIN, KRISTIN ELIZABETH —

Client Portfolio (93 clients)

View all 93 →

Top Art Units

Art UnitApps
16217
36294
36243
37923
37993
16753
17983
36232
37962
16522

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19560331 SYSTEMS AND METHODS FOR REVENUE INTELLIGENT DIGITAL ASSISTANT USING REAL-TIME DATA MESH Ingram Micro Inc. DELICH, STEPHANIE ZAGARELLA 3623 §101 Final Rejection — Pending Mar 09, 2026
19559235 SYSTEMS AND METHODS FOR DYNAMIC PRICING OPTIMIZATION BASED ON CUSTOMER WILLINGNESS TO PAY Ingram Micro Inc. STEWART, CRYSTOL 3624 §101§103§112 Non-Final OA — Pending Mar 06, 2026
19558117 HIGH STIFFNESS BOOSTER WITH COMPLIANT SUPPORT TABS AT NODE OR ANTINODE POSITIONS AND ULTRASONIC WELDING APPARATUS INCLUDING SAME Dukane Ias, LLC DO, NHAT CHIEU Q 3724 §102§103§112DP Non-Final OA — Pending Mar 05, 2026
19400243 SYSTEMS AND METHODS FOR MULTI-TIERED SUBSCRIPTION MANAGEMENT Ingram Micro Inc. GAVIN, KRISTIN ELIZABETH 3624 §101§103 Non-Final OA — Pending Nov 25, 2025
19396025 SYSTEMS AND METHODS FOR AUTOMATED CONFIGURATION TO ORDER AND QUOTE TO ORDER Ingram Micro Inc. ZEROUAL, OMAR 3629 §101§103 Non-Final OA — Pending Nov 20, 2025
19294170 METHOD AND SYSTEM FOR PROVIDING TECHNICAL SERVICE TO AN AGRICULTURAL WORKING MACHINE Claas Omaha Inc. GARCIA-GUERRA, DARLENE 3625 §101§103§112 Non-Final OA — Pending Aug 07, 2025
19236484 SUTURE MATERIALS, SUTURE PLACEMENT DEVICES AND METHODS OF SUTURE PLACEMENT AND TISSUE APPROXIMATION Tack Surgical, LLC MILLER, SERENITY A 3771 §102§112 Non-Final OA — Pending Jun 12, 2025
19189410 COMBINATION USES OF NITROXOLINE AND ITS ANALOGUES WITH CHEMOTHERAPIES AND IMMUNOTHERAPIES IN THE TREATMENT OF CANCERS Jiangsu Yahong Meditech Co., Ltd. JACKSON-TONGUE, LAKIA J 1645 §102§103Other Non-Final OA — Pending Apr 25, 2025
19171105 METHODS OF ENHANCING STEM CELL PRODUCTION All-Cells Healing, Inc. SKROBARCZYK III, ROBERT ANTHONY 3792 §101§112 Non-Final OA — Pending Apr 04, 2025
19088739 METHOD AND SYSTEM OF A COMMAND BUFFER BETWEEN A CPU AND GPU Oxide Interactive, Inc. HSU, JONI 2611 §103Other Non-Final OA — Pending Mar 24, 2025
19085265 METHODS TO TREAT LONG-COVID AND INFLUENZA Tesla Biohealing, LLC HOFFA, ANGELA MARIE 3799 §101§112 Non-Final OA — Pending Mar 20, 2025
19079608 COMPUTER PLANNING AGENT Oxide Interactive, Inc. GARNER, WERNER G 3715 §101§112 Non-Final OA — Pending Mar 14, 2025
19104621 COMPOSITION OF LIPID NANOPARTICLES Suzhou Abogen Biosciences Co., Ltd. PURDY, KYLE A 1611 §102§103 Non-Final OA — Pending Feb 18, 2025
19104677 ROOF STRUCTURE HAVING PHOTOVOLTAIC MODULES Mygreen Holding GmbH PATTERSON, GARRETT CHRISTOPHER 3633 §102§103 Non-Final OA — Pending Feb 18, 2025
19043248 METHODS TO TREAT PARKINSON'S DISEASE Brain Healing Inc. HOFFA, ANGELA MARIE 3799 §101§112 Non-Final OA — Pending Jan 31, 2025
19043212 METHODS TO TREAT GENE MUTATION AND MUSCULAR DEGENERATIVE DISEASE All-Cells Healing Inc. HOFFA, ANGELA MARIE 3799 §101§112 Non-Final OA — Pending Jan 31, 2025
19018798 AI-DRIVEN INTEGRATION PLATFORM AND USER-ADAPTIVE INTERFACE FOR BUSINESS RELATIONSHIP ORCHESTRATION Citizens Financial Group, Inc. CHIANG, JASON 2431 §103§112 Final Rejection — Pending Jan 13, 2025
19009885 METHODS TO MITIGATE SIDE EFFECTS OF CANCER TREATMENTS All-Cells Healing Inc. SISON, CHRISTINE ANDREA PAN 3796 §101§112 Non-Final OA — Pending Jan 03, 2025
18880475 COMBINATION THERAPIES INVOLVING L-ASPARAGINASE Jazz Pharmaceuticals Ireland Limited PAK, YONG D 1652 §102§103§112 Non-Final OA — Pending Dec 31, 2024
19005365 AUTOMATED MULTI-PARTY DOCUMENT MANAGEMENT PLATFORM AND USER INTERACTIVE TOOL Citizens Financial Group, Inc. WALTON, CHESIREE A 3624 §101§103 Non-Final OA — Pending Dec 30, 2024
19003616 SYSTEM AND METHOD FOR PAYROLL RECONCILIATION AND PAYMENT Salus Finance, LLC NOVAK, REBECCA R 3629 §101§103 Final Rejection — Pending Dec 27, 2024
19002457 DATA RESTORE SYSTEM Druva Inc. GUYTON, PHILIP A 2113 §101 Non-Final OA 3d overdue Pending Dec 26, 2024
19000016 METHOD, A COMPUTER PROGRAM AND A SYSTEM FOR SPERM QUALITY DETERMINATION Fundació Institut De Ciències Fotòniques THOMAS, MIA M 2665 §103 Non-Final OA — Pending Dec 23, 2024
18985291 ANTI-THEFT DEVICE FOR A TRANSPORT RAILCAR GRATING Holden America Il, LLC MCCARRY JR, ROBERT J 3615 §102 Non-Final OA — Pending Dec 18, 2024
18983692 MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF Foresee Pharmaceuticals Usa, Inc. ROBINSON, MIKHAIL O'DONNEL 1627 §103§112Other Non-Final OA — Pending Dec 17, 2024
18971858 LOW PROFILE HOLLOW RETROREFLECTOR ASSEMBLY AND THEIR MOUNTING STRUCTURES AND MOUNTING METHODS Plx, Inc. RAKOWSKI, CARA E 2872 §102§103§112 Non-Final OA — Pending Dec 06, 2024
18949952 SYSTEMS AND METHODS FOR INTEGRATING REAL-TIME BUSINESS INSIGHTS Ingram Micro Inc. ZEROUAL, OMAR 3629 §101§103§112 Final Rejection 34d Pending Nov 15, 2024
18938440 GUANIDINOACETIC ACID, ITS DERIVATES, COMPOSITIONS AND METHODS OF USE THEREOF Christopher Stahley ARCORIA, PAUL JOSEPH 1621 §103§112 Non-Final OA — Pending Nov 06, 2024
18905686 BRAKE PAD WEAR SENSOR Sadeca Systems, S.L.U. AUNG, SAN M 3616 §103 Non-Final OA — Pending Oct 03, 2024
18853244 IMMUNE ENHANCEMENT OF CANCER TREATMENT Institut D'Investigacions Biomédiques August Pi I Sunyer (Idibaps) ABBAS, ABDULRAHMAN MUSTAFA 1612 §103§112 Non-Final OA — Pending Oct 01, 2024
18895049 THORACOSTOMY DEVICE Ohiohealth Corporation MARCETICH, ADAM M 3781 §112DP Non-Final OA — Pending Sep 24, 2024
18828450 MULTI-MODAL DEVELOPMENT INTERFACE FOR LARGE LANGUAGE MODEL APPLICATIONS Gopal Datt Joshi O'CONNOR-EMANUEL, LAWRENCE SCOTT 2193 §101§102§103§112 Non-Final OA — Pending Sep 09, 2024
18844879 METHOD AND SYSTEM FOR LEAKAGE DETECTION IN A FLUID SYSTEM Grundfos Holding A/S BOLDUC, DAVID J 2852 §101§102§103 Non-Final OA — Pending Sep 06, 2024
18843180 SYSTEM AND METHOD FOR TREATMENT BY ELECTROPHYSIOLOGICAL STIMULATION TrueRelief, LLC ALTER MORSCHAUSER, ALYSSA MARGO 3796 §103Other Non-Final OA — Pending Aug 30, 2024
18817538 SYSTEMS AND METHODS FOR STANDARDIZING DEFINITION OF SOFTWARE ARCHITECTURES Facets Cloud Inc. MITCHELL, JASON D 2199 §101§102§103§112 Non-Final OA — Pending Aug 28, 2024
18810352 LIPID COMPOUND, LIPID NANOPARTICLE COMPRISING SAME AND USE THEREOF Themedium Therapeutics Co., Ltd. ARNOLD, ERNST V 1613 §102§103§112DP Non-Final OA — Pending Aug 20, 2024
18794654 KINETIC CARRIER DEVICE Degrees Of Freedom LLC CASTELLANO, STEPHEN J 3733 §102§112 Final Rejection 62d Pending Aug 05, 2024
18793346 SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS Ingram Micro Inc. ZEROUAL, OMAR 3629 §101§112 Final Rejection 147d overdue Pending Aug 02, 2024
18775244 ADJUSTABLE FLOW URINARY CATHETER Rethink Medical, S.L. LEVY, BRANDON WILLIAM 3781 §102§103§112 Non-Final OA — Pending Jul 17, 2024
18729134 STATISTICAL DATA ACQUISITION DEVICE, DEGREE OF CONTRIBUTION CALCULATION DEVICE, TREATMENT ACTION SEARCH DEVICE, TREATMENT OBJECT SEARCH DEVICE, STATISTICAL DATA ACQUISITION PROGRAM, DEGREE OF CONTRIBUTION CALCULATION PROGRAM, TREATMENT ACTION SEARCH PROGRAM, AND TREATMENT OBJECT SEARCH PROGRAM Aizoth Inc. LEE, ANDREW ELDRIDGE 3684 §101§102§103 Final Rejection 72d overdue Pending Jul 15, 2024
18727456 SILICONE GEL COMPOSITION OF WALNUT EXTRACT Hartington Business, S. L. MOEHLMAN, ANDREW TERRY 1655 §103§112 Non-Final OA — Pending Jul 09, 2024
18752729 HAND-HELD PULLING AND COMPRESSION DEVICE Tkr Spezialwerkzeuge GmbH CHIN, PAUL T 3725 §112 Non-Final OA — Pending Jun 24, 2024
18723323 METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE Reddress Ltd. PEEBLES, KATHERINE 1617 §103§112DP Non-Final OA — Pending Jun 21, 2024
18750890 DEVICE AND METHOD FOR PREDICTING PATHOLOGIC FRACTURE IN PROXIMAL FEMUR, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING PROGRAM FOR PERFORMING THE METHOD The Catholic University Of Korea Industry-Academic Cooperation Foundation MACCAGNO, PIERRE L 3687 §101§102§103 Final Rejection — Pending Jun 21, 2024
18722532 RELIABLE OPTICAL TRANSIT TIME METHOD FOR DETERMINING DISTANCE VALUES K.A. Schmersal Holding GmbH & Co. Kg WOLDEMARYAM, ASSRES H 3642 §102§103§112 Non-Final OA — Pending Jun 20, 2024
18735463 BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE Tesla Biohealing, Inc. TRUONG, QUANGLONG N 1615 §103 Non-Final OA — Pending Jun 06, 2024
18577053 SMALL MOLECULE COMPOUND TARGETING BCL9/BETA-CATENIN INTERACTION Nantong Jutai Biotech Co., Ltd. KOSTURKO, GEORGE W 1621 §102§103§112 Non-Final OA — Pending Jun 06, 2024
18716469 METHOD AND APPARATUS FOR DETECTING HYDRAULIC SHOCK Grundfos Holding A/S TIMILSINA, SHARAD 2853 §103§112 Non-Final OA — Pending Jun 04, 2024
18714054 HANDHELD PULLING AND COMPRESSING DEVICE Tkr Spezialwerkzeuge GmbH WILSON, LEE D 3723 §102 Final Rejection — Pending May 28, 2024
18712989 DAROLUTAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF Sinotherapeutics Inc. PARK, HAEJIN S 1614 §102§103§112 Non-Final OA — Pending May 23, 2024

View all 123 →

Managing Ice Miller LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Ice Miller LLP's patent allowance rate?

84.0% of resolved applications prosecuted by Ice Miller LLP were allowed, across 4,333 applications in USPTO records.

How many office actions does Ice Miller LLP average before allowance?

3.24 office actions per allowed application on average.

How many pending office actions does Ice Miller LLP have?

123 pending office actions as of October 2026, for 93 clients, before 118 examiners in 88 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month